Use of Forward-Looking Statements
This communication includes certain forward-looking statements within the meaning of, and subject to the safe harbor created by, the federal
securities laws, including statements related to the proposed merger of SP Plus Corporation (the Company) with an affiliate of Metropolis Technologies, Inc. (Metropolis) (the Transaction), including financial
estimates and statements as to the expected timing, completion and effects of the Transaction. These forward-looking statements are based on the Companys current expectations, estimates and projections regarding, among other things, the
expected date of closing of the Transaction and the potential benefits thereof, its business and industry, managements beliefs and certain assumptions made by the Company, all of which are subject to change. Forward-looking statements often
contain words such as expect, anticipate, intend, aims, plan, believe, could, seek, see, will, may,
would, might, considered, potential, estimate, continue, likely, expect, target or similar expressions or the negatives of these words or
other comparable terminology that convey uncertainty of future events or outcomes. By their nature, forward-looking statements address matters that involve risks and uncertainties because they relate to events and depend upon future circumstances
that may or may not occur, such as the consummation of the Transaction and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that
could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the completion of the Transaction on
anticipated terms and timing, including obtaining required stockholder and regulatory approvals, and the satisfaction of other conditions to the completion of the Transaction; (ii) the ability of Metropolis to obtain the necessary financing
arrangements set forth in the commitment letters received in connection with the Transaction; (iii) potential litigation relating to the Transaction that could be instituted against Metropolis, the Company or their respective directors,
managers or officers, including the effects of any outcomes related thereto; (iv) the risk that disruptions from the Transaction will harm the Companys business, including current plans and operations; (v) the ability of the Company
to retain and hire key personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating
agency actions; (viii) legislative, regulatory and economic developments affecting the Companys business; (ix) general economic and market developments and conditions; (x) potential business uncertainty, including changes to
existing business relationships, during the pendency of the Transaction that could affect the Companys financial performance; (xi) certain restrictions during the pendency of the Transaction that may impact the Companys ability to
pursue certain business opportunities or strategic transactions; (xii) unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, pandemics, outbreaks of war or hostilities, as well as the
Companys response to any of the aforementioned factors; (xiii) significant transaction costs associated with the Transaction; (xiv) the possibility that the Transaction may be more expensive to complete than anticipated, including as
a result of unexpected factors or events; (xv) the occurrence of any event, change or other circumstance that could give rise to the termination of the Transaction, including in circumstances requiring the Company to pay a termination fee or
other expenses; (xvi) competitive responses to the Transaction; (xvii) the risks and uncertainties pertaining to the Companys business, including those set forth in Part I, Item 1A of the Companys most recent Annual Report on
Form 10-K and Part II, Item 1A of the Companys subsequent Quarterly Reports on Form 10-Q, as such risk factors may be amended,